Detalles de la búsqueda
1.
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.
Future Oncol
; 2023 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36617990
2.
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Am J Hematol
; 94(12): 1353-1363, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31512258
3.
The small G protein RAS2 is involved in the metabolic compensation of the circadian clock in the circadian model Neurospora crassa.
J Biol Chem
; 292(36): 14929-14939, 2017 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28729421
4.
[Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia]. / Familiáris myelodysplasiás szindróma és akut myeloid leukaemia klinikai és genetikai háttere.
Orv Hetil
; 157(8): 283-9, 2016 Feb 21.
Artículo
en Húngaro
| MEDLINE | ID: mdl-26876264
5.
Adaptation to glucose starvation is associated with molecular reorganization of the circadian clock in Neurospora crassa.
Elife
; 122023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625037
6.
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 29(14): 2593-2601, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37282671
7.
Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma.
Leuk Lymphoma
; 63(7): 1580-1588, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35227147
8.
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.
Blood Adv
; 6(11): 3440-3450, 2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377947
9.
Expression of the translation termination factor eRF1 is autoregulated by translational readthrough and 3'UTR intron-mediated NMD in Neurospora crassa.
FEBS Lett
; 594(21): 3504-3517, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32869294
10.
First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis.
Hemasphere
; 8(5): e74, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38803455
11.
Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Pathol Oncol Res
; 24(1): 83-88, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28357685
12.
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.
JAMA Oncol
; 4(5): 652-659, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29522138
13.
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.
Leuk Res
; 65: 42-48, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29306106
14.
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial.
Lancet Haematol
; 4(5): e225-e236, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28336242
15.
Stroke in essential thrombocythemia.
J Neurol Sci
; 336(1-2): 260-2, 2014 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183283
Resultados
1 -
15
de 15
1
Próxima >
>>